Engineered human mesenchymal stem cells as new vaccine platform for COVID-19
Liu, J.; Jiao, H.; Yin, X.
Show abstract
Recently, there are several routes for COVID-19 vaccine research, yet their weaknesses lie in low efficiency, tolerability, immune adaptability and safety. We describe a new approach to COVID-19 based on engineered human mesenchymal stem cells(hu-MSC), which is like a small protein antigen response device, but will be gradually cleared and degraded by bodys immune system among recognization process. The antibody response results show that this is effective and fast. Furthermore, after several antibody response tests, we obtained an injection of a set of cocktail-like modified human mesenchymal stem cell line. This strategy opened a new avenue for vaccine design against COVID-19.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Mesenchymal stem cell suppresses the efficacy of CAR-T toward killing lymphoma cells by modulating the microenvironment through stanniocalcin-1 96%
- Mapping of single-cell landscape of acral melanoma and analysis of molecular regulatory network of tumor microenvironment 93%
- A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants 92%
Similar papers in this journal
- A hemoperfusion column selectively adsorbs LAP+ lymphocytes to improve anti-tumor immunity and survival of tumor-bearing rats 94%
- Research of the mechanism on miRNA193 in exosomes promotes cisplatin resistance in esophageal cancer cells 94%
- The up-regulation of TGF-beta1 by miRNA-132-3p/WT1 is involved in inducing leukemia cells to differentiate into macrophages 94%
Similar papers in this journal
- Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses 92%
- Basement membrane extract potentiates the endochondral ossification phenotype of bone marrow-derived mesenchymal stem cell-based cartilage organoids 91%
- Angiotensin II induces apoptosis in human induced pluripotent stem cell-derived cardiomyocytes 91%
Similar papers in this journal
- Pre-clinical Research of Human Amnion-derived Mesenchymal Stem Cells and its First Clinical Treatment for a Severe Uremic Calciphylaxis Patient 94%
- Identification and Characterization of Stem Cells in Mammalian Esophageal Stratified Squamous Epithelia 91%
- Kidney injury molecule-1 is a potential receptor for SARS-CoV-2 88%
Similar papers in this journal
- Myogenetic oligodeoxynucleotides as anti-nucleolin aptamers inhibit the growth of embryonal rhabdomyosarcoma cells 94%
- MicroRNAs and mRNA Regulatory Network of Parenchymal Hematoma after Endovascular Mechanical Reperfusion for Acute Ischemic Stroke in Rat 93%
- UBL3 Interacts with Alpha-synuclein in Cells and the Interaction is Downregulated by the EGFR Pathway Inhibitor Osimertinib 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.